Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.

CompletedOBSERVATIONAL

Enrollment

461

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions

Advanced Prostate Cancer

Interventions

DRUG

Degarelix

According to medical practice

DRUG

LHRH agonist (Leuprorelinacetat, Goserelinacetat, Buserelinacetat, Triptorelinacetat)

According to medical practice

Trial Locations (1)

Investigational site (there may be other sites in this country), Rottweil